Lv61
1720 积分 2022-05-06 加入
Preclinical development of SL-325, a novel high-affinity DR3-blocking antibody for durable inhibition of the DR3/TL1A axis in inflammatory bowel disease
5天前
已关闭
mRNA 3′ UTRs chaperone intrinsically disordered regions to control protein activity
26天前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
1个月前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
1个月前
已完结
The weight-loss-independent hepatoprotective benefits of semaglutide are orchestrated by intrahepatic sinusoidal endothelial GLP-1 receptors
1个月前
已完结
Pre-clinical and translational pharmacology of a human interleukin-22 IgG fusion protein for potential treatment of infectious or inflammatory diseases
2个月前
已关闭
TL1A regulates adipose-resident innate lymphoid immune responses and enables diet-induced obesity in mice
2个月前
已完结
Single-cell RNA-seq identifies a PD-1hi ILC progenitor and defines its development pathway
2个月前
已完结
IL-22 activates ISCs for intestinal regeneration
3个月前
已关闭
B cell depletion in autoimmune disease: in vivo CAR-T or T cell engagers?
3个月前
已完结
皖公网安备34019202002308
